{"id":49239,"date":"2022-10-06T12:01:56","date_gmt":"2022-10-06T10:01:56","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\/"},"modified":"2022-10-06T12:01:56","modified_gmt":"2022-10-06T10:01:56","slug":"the-geo-group-publishes-fourth-annual-human-rights-and-esg-report","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\/","title":{"rendered":"The GEO Group Publishes Fourth Annual Human Rights and ESG Report"},"content":{"rendered":"<div>\n<p>BOCA RATON, Fla.&#8211;(BUSINESS WIRE)&#8211;<b>The GEO Group, Inc. (NYSE: GEO)<\/b> (\u201cGEO\u201d or the \u201cCompany\u201d) published today the company\u2019s fourth annual Human Rights and Environmental, Social &amp; Governance (ESG) report. The report includes enhanced disclosures related to our Board oversight of human rights and ESG matters, employee diversity and training programs, corporate governance, and environmental sustainability, including updated metrics and statistics for the calendar year 2021, in accordance with the new Universal Standards of the Global Reporting Initiative (GRI).\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221005005798\/en\/1593462\/5\/01-GEO-Corp.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221005005798\/en\/1593462\/21\/01-GEO-Corp.jpg\"><\/a><\/p>\n<p>\nThe report also highlights GEO\u2019s continued commitment to providing enhanced rehabilitation and post-release support services through our award-winning GEO Continuum of Care\u00ae (CoC) program. During 2021, our CoC facilities delivered approximately 2.8 million hours of enhanced rehabilitation programming. The CoC program integrates enhanced offender rehabilitation, including cognitive behavioral treatment, with post-release support services to address basic community needs of released individuals, including housing, transportation, food, clothing, and job placement assistance.\n<\/p>\n<p>\nGEO\u2019s Executive Chairman, George C. Zoley, said: \u201cThe publication of our fourth annual Human Rights and ESG report highlights our continued commitment to respecting the human rights and improving the lives of those entrusted to our care. Our Board committee structure has been expanded to include two new committees. One dedicated committee to oversee Criminal Justice Rehabilitation and Human Rights matters, and another dedicated committee to oversee Cyber Security and Environmental Oversight matters. We also recently undertook a Human Rights Due Diligence Assessment. The results of this due diligence assessment have been incorporated into this year\u2019s ESG report. Moving forward, we expect to evaluate additional human rights initiatives, including a future review of our Global Human Rights Policy and its implementation.\u201d\n<\/p>\n<p>\nA copy of GEO\u2019s fourth annual Human Rights and ESG Report can be found at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.geogroup.com%2FESG&amp;esheet=52938238&amp;newsitemid=20221005005798&amp;lan=en-US&amp;anchor=www.geogroup.com%2Fesg&amp;index=1&amp;md5=f1e2aa4a9192ae6bf70e8ee744fe3c86\" rel=\"nofollow noopener\" shape=\"rect\">www.geogroup.com\/esg<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwearegeo.com%2Fesg%2F&amp;esheet=52938238&amp;newsitemid=20221005005798&amp;lan=en-US&amp;anchor=www.wearegeo.com%2Fesg&amp;index=2&amp;md5=f500bab8ac5e012ccf2d6bc0b0cea26a\" rel=\"nofollow noopener\" shape=\"rect\">www.wearegeo.com\/esg<\/a>.\n<\/p>\n<p>\n<b>About The GEO Group<\/b>\n<\/p>\n<p>\nThe GEO Group, Inc. (NYSE: GEO) is a leading diversified government service provider, specializing in design, financing, development, and support services for secure facilities, processing centers, and community reentry centers in the United States, Australia, South Africa, and the United Kingdom. GEO\u2019s diversified services include enhanced in-custody rehabilitation and post-release support through the award-winning GEO Continuum of Care\u00ae, secure transportation, electronic monitoring, community-based programs, and correctional health and mental health care. GEO\u2019s worldwide operations include the ownership and\/or delivery of support services for 102 facilities totaling approximately 82,000 beds, including idle facilities and projects under development, with a workforce of up to approximately 18,000 employees.\n<\/p>\n<p>\n<b>Use of forward-looking statements<\/b>\n<\/p>\n<p>\nThis news release may contain \u201cforward-looking statements\u201d within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements and any such forward-looking statements are qualified in their entirety by reference to the following cautionary statements. All forward-looking statements speak only as of the date of this news release and are based on current expectations and involve a number of assumptions, risks and uncertainties that could cause the actual results to differ materially from such forward-looking statements. Readers are strongly encouraged to read the full cautionary statements and risk factors contained in GEO\u2019s filings with the U.S. Securities and Exchange Commission, including its Form 10-K, 10-Q and 8-K reports. GEO disclaims any obligation to update or revise any forward-looking statements.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nPablo E. Paez<br \/>\n<br \/>Executive Vice President, Corporate Relations<br \/>\n<br \/>1-866-301-4436\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOCA RATON, Fla.&#8211;(BUSINESS WIRE)&#8211;The GEO Group, Inc. (NYSE: GEO) (\u201cGEO\u201d or the \u201cCompany\u201d) published today the company\u2019s fourth annual Human Rights and Environmental, Social &amp; Governance (ESG) report. The report includes enhanced disclosures related to our Board oversight of human rights and ESG matters, employee diversity and training programs, corporate governance, and environmental sustainability, including &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49239","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The GEO Group Publishes Fourth Annual Human Rights and ESG Report - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The GEO Group Publishes Fourth Annual Human Rights and ESG Report - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BOCA RATON, Fla.&#8211;(BUSINESS WIRE)&#8211;The GEO Group, Inc. (NYSE: GEO) (\u201cGEO\u201d or the \u201cCompany\u201d) published today the company\u2019s fourth annual Human Rights and Environmental, Social &amp; Governance (ESG) report. The report includes enhanced disclosures related to our Board oversight of human rights and ESG matters, employee diversity and training programs, corporate governance, and environmental sustainability, including ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-06T10:01:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221005005798\/en\/1593462\/21\/01-GEO-Corp.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"The GEO Group Publishes Fourth Annual Human Rights and ESG Report\",\"datePublished\":\"2022-10-06T10:01:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\\\/\"},\"wordCount\":579,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221005005798\\\/en\\\/1593462\\\/21\\\/01-GEO-Corp.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\\\/\",\"name\":\"The GEO Group Publishes Fourth Annual Human Rights and ESG Report - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221005005798\\\/en\\\/1593462\\\/21\\\/01-GEO-Corp.jpg\",\"datePublished\":\"2022-10-06T10:01:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221005005798\\\/en\\\/1593462\\\/21\\\/01-GEO-Corp.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221005005798\\\/en\\\/1593462\\\/21\\\/01-GEO-Corp.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The GEO Group Publishes Fourth Annual Human Rights and ESG Report\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The GEO Group Publishes Fourth Annual Human Rights and ESG Report - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\/","og_locale":"en_US","og_type":"article","og_title":"The GEO Group Publishes Fourth Annual Human Rights and ESG Report - Pharma Trend","og_description":"BOCA RATON, Fla.&#8211;(BUSINESS WIRE)&#8211;The GEO Group, Inc. (NYSE: GEO) (\u201cGEO\u201d or the \u201cCompany\u201d) published today the company\u2019s fourth annual Human Rights and Environmental, Social &amp; Governance (ESG) report. The report includes enhanced disclosures related to our Board oversight of human rights and ESG matters, employee diversity and training programs, corporate governance, and environmental sustainability, including ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-06T10:01:56+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221005005798\/en\/1593462\/21\/01-GEO-Corp.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"The GEO Group Publishes Fourth Annual Human Rights and ESG Report","datePublished":"2022-10-06T10:01:56+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\/"},"wordCount":579,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221005005798\/en\/1593462\/21\/01-GEO-Corp.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\/","url":"https:\/\/pharma-trend.com\/en\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\/","name":"The GEO Group Publishes Fourth Annual Human Rights and ESG Report - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221005005798\/en\/1593462\/21\/01-GEO-Corp.jpg","datePublished":"2022-10-06T10:01:56+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221005005798\/en\/1593462\/21\/01-GEO-Corp.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221005005798\/en\/1593462\/21\/01-GEO-Corp.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/the-geo-group-publishes-fourth-annual-human-rights-and-esg-report\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"The GEO Group Publishes Fourth Annual Human Rights and ESG Report"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49239"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49239\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49239"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49239"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}